Cargando…
B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
The generation of high-affinity antibodies requires somatic hypermutation (SHM) and class switch recombination (CSR) at the immunoglobulin (Ig) locus. Both processes are triggered by activation-induced cytidine deaminase (AID) and require UNG-encoded uracil-DNA glycosylase. AID has been suggested to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212036/ https://www.ncbi.nlm.nih.gov/pubmed/15967827 http://dx.doi.org/10.1084/jem.20050042 |
_version_ | 1782148609089732608 |
---|---|
author | Kavli, Bodil Andersen, Sonja Otterlei, Marit Liabakk, Nina B. Imai, Kohsuke Fischer, Alain Durandy, Anne Krokan, Hans E. Slupphaug, Geir |
author_facet | Kavli, Bodil Andersen, Sonja Otterlei, Marit Liabakk, Nina B. Imai, Kohsuke Fischer, Alain Durandy, Anne Krokan, Hans E. Slupphaug, Geir |
author_sort | Kavli, Bodil |
collection | PubMed |
description | The generation of high-affinity antibodies requires somatic hypermutation (SHM) and class switch recombination (CSR) at the immunoglobulin (Ig) locus. Both processes are triggered by activation-induced cytidine deaminase (AID) and require UNG-encoded uracil-DNA glycosylase. AID has been suggested to function as an mRNA editing deaminase or as a single-strand DNA deaminase. In the latter model, SHM may result from replicative incorporation of dAMP opposite U or from error-prone repair of U, whereas CSR may be triggered by strand breaks at abasic sites. Here, we demonstrate that extracts of UNG-proficient human B cell lines efficiently remove U from single-stranded DNA. In B cell lines from hyper-IgM patients carrying UNG mutations, the single-strand–specific uracil-DNA glycosylase, SMUG1, cannot complement this function. Moreover, the UNG mutations lead to increased accumulation of genomic uracil. One mutation results in an F251S substitution in the UNG catalytic domain. Although this UNG form was fully active and stable when expressed in Escherichia coli, it was mistargeted to mitochondria and degraded in mammalian cells. Our results may explain why SMUG1 cannot compensate the UNG2 deficiency in human B cells, and are fully consistent with the DNA deamination model that requires active nuclear UNG2. Based on our findings and recent information in the literature, we present an integrated model for the initiating steps in CSR. |
format | Text |
id | pubmed-2212036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22120362008-03-11 B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil Kavli, Bodil Andersen, Sonja Otterlei, Marit Liabakk, Nina B. Imai, Kohsuke Fischer, Alain Durandy, Anne Krokan, Hans E. Slupphaug, Geir J Exp Med Article The generation of high-affinity antibodies requires somatic hypermutation (SHM) and class switch recombination (CSR) at the immunoglobulin (Ig) locus. Both processes are triggered by activation-induced cytidine deaminase (AID) and require UNG-encoded uracil-DNA glycosylase. AID has been suggested to function as an mRNA editing deaminase or as a single-strand DNA deaminase. In the latter model, SHM may result from replicative incorporation of dAMP opposite U or from error-prone repair of U, whereas CSR may be triggered by strand breaks at abasic sites. Here, we demonstrate that extracts of UNG-proficient human B cell lines efficiently remove U from single-stranded DNA. In B cell lines from hyper-IgM patients carrying UNG mutations, the single-strand–specific uracil-DNA glycosylase, SMUG1, cannot complement this function. Moreover, the UNG mutations lead to increased accumulation of genomic uracil. One mutation results in an F251S substitution in the UNG catalytic domain. Although this UNG form was fully active and stable when expressed in Escherichia coli, it was mistargeted to mitochondria and degraded in mammalian cells. Our results may explain why SMUG1 cannot compensate the UNG2 deficiency in human B cells, and are fully consistent with the DNA deamination model that requires active nuclear UNG2. Based on our findings and recent information in the literature, we present an integrated model for the initiating steps in CSR. The Rockefeller University Press 2005-06-20 /pmc/articles/PMC2212036/ /pubmed/15967827 http://dx.doi.org/10.1084/jem.20050042 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Kavli, Bodil Andersen, Sonja Otterlei, Marit Liabakk, Nina B. Imai, Kohsuke Fischer, Alain Durandy, Anne Krokan, Hans E. Slupphaug, Geir B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil |
title | B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil |
title_full | B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil |
title_fullStr | B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil |
title_full_unstemmed | B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil |
title_short | B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil |
title_sort | b cells from hyper-igm patients carrying ung mutations lack ability to remove uracil from ssdna and have elevated genomic uracil |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212036/ https://www.ncbi.nlm.nih.gov/pubmed/15967827 http://dx.doi.org/10.1084/jem.20050042 |
work_keys_str_mv | AT kavlibodil bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil AT andersensonja bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil AT otterleimarit bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil AT liabakkninab bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil AT imaikohsuke bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil AT fischeralain bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil AT durandyanne bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil AT krokanhanse bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil AT slupphauggeir bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil |